PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Oct-2021 U.S. and China Glucose Market Trends, Analysis & Forecasts 2021-2028 by Form (Syrup, Solid), & Applications (Food & Beverages, Cosmetic & Personal Care, Pharmaceutical) - ResearchAndMarkets.com Businesswire
04-Oct-2021 Global Clinical Oncology Next Generation Sequencing Market Analysis Report 2021 - ResearchAndMarkets.com Businesswire
04-Oct-2021 „Medicine Miles“ werden zu einem Problem für europäische Patienten Businesswire
04-Oct-2021 LB Pharmaceuticals Presents Results of Dopamine Receptor Occupancy Studies of LB-102 at ECNP Conference Businesswire
04-Oct-2021 Cell Based Assay & High Content Screening Markets, Q3 2021 Report - ResearchAndMarkets.com Businesswire
04-Oct-2021 United States e-Pharmacy Market Report 2021: Increased Awareness Among Consumers Regarding the Availability of Drugs and Therapeutics Delivered Direct to their Door - ResearchAndMarkets.com Businesswire
04-Oct-2021 Stevanato Group Initiates Construction on New U.S. Facility Businesswire
04-Oct-2021 TriMas’ Rieke Business Celebrates 100-Year Milestone Businesswire
04-Oct-2021 Mawi DNA Technologies Announces Partnership with FUJIFILM Businesswire
04-Oct-2021 The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2022 Prize for Early-Career, Radically Innovative Cancer Researchers Businesswire
04-Oct-2021 Updated Vitrakvi® (larotrectinib) Sub-Analysis at ATA 2021 Supports Efficacy and Safety in Adult and Pediatric TRK Fusion Thyroid Cancer Patients Businesswire
04-Oct-2021 National Cancer Institute Selects ImmunityBio’s N-803 IL-15 Receptor Agonist to Combine with Keytruda in 700-Site Lung-MAP Clinical Trial of a Chemo-Free Therapy Businesswire
04-Oct-2021 Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer Businesswire
04-Oct-2021 Heritage Cannabis Announces Supply Agreements and First Shipment of Opticann Medical Products to Australia Businesswire
04-Oct-2021 Atara Biotherapeutics and Pierre Fabre Enter Strategic Collaboration to Commercialize Tabelecleucel (Tab-cel®) Businesswire
04-Oct-2021 Boston Pharmaceuticals Doses First Patient in Phase 2a Clinical Trial of BOS-580 for NASH Businesswire
04-Oct-2021 Enanta Pharmaceuticals Provides Update on NASH FXR Agonist Programs Businesswire
04-Oct-2021 LianBio Appoints Michael Humphries as Chief Scientific Advisor Businesswire
04-Oct-2021 SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19 Businesswire
04-Oct-2021 Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies Businesswire